204 related articles for article (PubMed ID: 31628556)
1. ASO Author Reflections: Current Status of Treatment of Peritoneal Carcinomatosis from Gastric Cancer Origin in Spain: Is It Possible to Cure These Patients?
Manzanedo I; Pereira F
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):792-793. PubMed ID: 31628556
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases.
Chia DKA; Ang JJ; Sundar R; Kim G; Shabbir A; So JBY; Yong WP
Ann Surg Oncol; 2022 Dec; 29(13):8606-8607. PubMed ID: 36192514
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis.
Baumgartner JM; Kurzrock R
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):772-773. PubMed ID: 30421042
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Achieving Long-Term Survival in Patients with Peritoneal Carcinomatosis of Colorectal Origin.
Sarfaty E; Cohen NA
Ann Surg Oncol; 2024 Mar; 31(3):2010-2011. PubMed ID: 38063982
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Time to Change: Redefining "Complete Cytoreduction" in Appendiceal Carcinomatosis.
Munoz-Zuluaga C; King MC; Gushchin V; Sardi A
Ann Surg Oncol; 2020 Dec; 27(13):5037-5038. PubMed ID: 32935268
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Postoperative Inflammatory Markers as a Surveillance Tool in Colorectal Peritoneal Carcinomatosis.
Tan JW; Thiagarajan S; Zhou S; Tan QX; Hendrikson J; Ng WH; Ng G; Liu Y; Wong JSM; Tan GHC; Soo KC; Teo MCC; Chia CS; Ong CJ
Ann Surg Oncol; 2021 Oct; 28(11):6636-6637. PubMed ID: 33733373
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer.
Sammartino P; Cornali T
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):882-883. PubMed ID: 30288653
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases.
Sluiter NR; Tuynman JB
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):840-841. PubMed ID: 30302638
[No Abstract] [Full Text] [Related]
9. Carcinomatosis in gastric cancer: the potential for cytoreductive surgery and intraperitoneal chemotherapy.
Ilson DH
Chin Clin Oncol; 2020 Apr; 9(2):24. PubMed ID: 32008326
[No Abstract] [Full Text] [Related]
10. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial.
Wang P; Zhou ZX
Ann Surg Oncol; 2017 Dec; 24(Suppl 3):623. PubMed ID: 29076044
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Long-Term Outcomes After R0 Resection of Colorectal Peritoneal Metastasis.
Shida D
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):832-833. PubMed ID: 30251024
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Predicting Hyperthermia and Its Effect in Patients with Peritoneal Surface Malignancies.
Guerra-Londono CE; Owusu-Agyemang P; Corrales G; Rofaeil MM; Feng L; Fournier K; Cata JP
Ann Surg Oncol; 2022 Mar; 29(3):2100-2101. PubMed ID: 34713370
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Pathologic Classification of Pseudomyxoma Peritonei.
Baratti D
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):844-845. PubMed ID: 30324483
[No Abstract] [Full Text] [Related]
14. Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
López-Basave HN; Quiroz-Sandoval OA; Padilla-Rosciano AE; León-Takahashi AM; Miranda-Devora G; Arrollo-Monroy A
Cir Cir; 2018; 86(3):277-284. PubMed ID: 29950734
[TBL] [Abstract][Full Text] [Related]
15. ASO Author Reflections: Long-Term Survival Is Feasible After Complete CRS/HIPEC for Biphasic Peritoneal Mesothelioma.
Chouliaras K; Votanopoulos KI
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):770-771. PubMed ID: 30421064
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Gastric Cancer with Peritoneal Metastasis: Are Some Patients Surgical Candidates?
Pimiento JM; Dineen SP
Ann Surg Oncol; 2021 Aug; 28(8):4138-4139. PubMed ID: 33866470
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Can Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy be Improved?
Graf W; Birgisson H
Ann Surg Oncol; 2020 Jan; 27(1):301-302. PubMed ID: 31520210
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Safety of Abdominal Surgical Cytoreduction Combined with Locoregional Chemohyperthermia.
Piso P
Ann Surg Oncol; 2019 Jan; 26(1):155. PubMed ID: 30478632
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Lee ZJ; Teo CCM
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):757-758. PubMed ID: 30374919
[No Abstract] [Full Text] [Related]
20. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O;
Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
